HEMISPHERX BIOPHARMA INC Business Operations Contracts & Agreements

50 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated Material Transfer and Research Agreement between AIM ImmunoTech, Inc. and Roswell Park Cancer Institute Corporation
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2023
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Japanese National Institute of Infectious Disease
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2023
Co-ordination Agreement among Erasmus University Medical Center, AIM ImmunoTech Inc., and AstraZeneca BV for DURIPANC Study
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Investigator Initiated Study Support Agreement between Erasmus University Medical Center Rotterdam and AIM ImmunoTech Inc.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Material Transfer Agreement between AIM ImmunoTech Inc. and University of Pittsburgh – Of the Commonwealth System of Higher Education
Supply Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and University of Pittsburgh
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Termination Agreement between AIM Immunotech, Inc. and Shenzhen Smoore Technology Limited
Termination Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Project Work Order Proposal between Amarex Clinical Research, LLC and AIM ImmunoTech Inc. for Phase II Ampligen Trial Services
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Project Work Order Proposal between Amarex Clinical Research, LLC and AIM ImmunoTech Inc. for Phase II Pancreatic Cancer Study
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Amendment to Renewed Sales, Marketing, Distribution and Supply Agreement between AIM ImmunoTech Inc. and GP Pharm
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and University of Cagliari
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
FL
2021
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Roswell Park Cancer Institute
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2021
Amendment 1 to Project AIM02 Statement of Work and Budget between AIM ImmunoTech Inc. and Amarex Clinical Research, LLC
Development Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Leyden Laboratories B.V.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
FL
2021
Clinical Trial Services Agreement between AIM ImmunoTech Inc. and Centre for Human Drug Research (CHDR)
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
DE
2021
Project Work Order Proposal between AIM ImmunoTech, Inc. and Amarex Clinical Research, LLC for Phase I/II Ampligen Clinical Trial
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2020
Clinical Trial Agreement between Roswell Park Cancer Institute and AIM ImmunoTech Inc. for Phase 1b Rintatolimod/IFNα Study
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Material Transfer and Research Agreement between AIM ImmunoTech Inc., Japanese National Institute of Infectious Disease, and Shionogi & Co., Ltd.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Material Transfer and Research Agreement between AIM ImmunoTech, Inc. and University of Rochester
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Material Transfer and Research Agreement between AIM ImmunoTech, Inc. and Shenzhen Smoore Technology Limited
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Amendment No. 1 to Material Transfer and Research Agreement between AIM ImmunoTech Inc. and Roswell Park Cancer Institute Corporation
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2020
Clinical Trial Agreement between Roswell Park Cancer Institute Corporation and Hemispherx Biopharma, Inc.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NY
2018
Amendment No. 2 to Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
Financial Advisory and Placement Agent Agreement between Hemispherx Biopharma, Inc. and Ascendiant Capital Markets, LLC
Advisory Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2018
Amended and Restated Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Collaboration Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2017
Amended and Restated Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V.
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2017
Sales, Marketing, Distribution, and Supply Agreement between Hemispherx and Scientific Products Pharmaceutical Co. LTD
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2016
Exclusive Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V. (myTomorrows)
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2015
Sales, Marketing, Distribution, and Supply Agreement between Hemispherx and Emerge Health for Alferon in Australia and New Zealand
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
NJ
2015
Early Access Agreement between Hemispherx Biopharma, Inc. and Impatients N.V. (myTomorrows)
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2015
Sales, Marketing, Distribution, and Supply Agreement between Hemispherx and Emerge Health Pty Ltd. for Ampligen in Australia and New Zealand
Distribution Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2015
Master Services Agreement between Sterling Pharma Solutions Limited and AIM ImmunoTech Inc. (December 5, 2022)
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Change Order No. 1 to Service Agreement for Method Transfer and Placebo Batch Manufacturing between AIM ImmunoTech Inc. and Pharmaceutics International, Inc.
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2022
Clinical Trial Agreement between hVIVO Services Ltd and AIM ImmunoTech Inc.
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Reservation and Start-up Agreement between hVIVO Services Limited and AIM ImmunoTech Inc.
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
First Amendment to Manufacture and Supply Agreement between Pharmaceutics International, Inc. and AIM Immuno Tech Inc.
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2021
Manufacturing and Technical Transfer Agreement between AIM ImmunoTech Inc. and Pharmaceutics International, Inc. for Ampligen (Rintatolimod)
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
DE
2021
Specialized Services Agreement between Utah State University and AIM ImmunoTech, Inc.
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
UT
2020
Fill/Finish Manufacturing Agreement between Avrio Biopharmaceuticals LLC and Hemispherx Biopharma, Inc. for Ampligen® Bulk Drug
Services Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
DE
2016
Advisors Agreement between Hemispherx BioPharma, Inc. and The Sage Group, Inc. dated June 15, 2013
Advisory Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
PA
2013